Sugar-Phosphate Toxicities.

antimicrobials drug targets fructose-asparagine sugar phosphate toxicity

Journal

Microbiology and molecular biology reviews : MMBR
ISSN: 1098-5557
Titre abrégé: Microbiol Mol Biol Rev
Pays: United States
ID NLM: 9706653

Informations de publication

Date de publication:
15 12 2021
Historique:
pubmed: 30 9 2021
medline: 15 1 2022
entrez: 29 9 2021
Statut: ppublish

Résumé

Accumulation of phosphorylated intermediates during cellular metabolism can have wide-ranging toxic effects on many organisms, including humans and the pathogens that infect them. These toxicities can be induced by feeding an upstream metabolite (a sugar, for instance) while simultaneously blocking the appropriate metabolic pathway with either a mutation or an enzyme inhibitor. Here, we survey the toxicities that can arise in the metabolism of glucose, galactose, fructose, fructose-asparagine, glycerol, trehalose, maltose, mannose, mannitol, arabinose, and rhamnose. Select enzymes in these metabolic pathways may serve as novel therapeutic targets. Some are conserved broadly among prokaryotes and eukaryotes (e.g., glucose and galactose) and are therefore unlikely to be viable drug targets. However, others are found only in bacteria (e.g., fructose-asparagine, rhamnose, and arabinose), and one is found in fungi but not in humans (trehalose). We discuss what is known about the mechanisms of toxicity and how resistance is achieved in order to identify the prospects and challenges associated with targeted exploitation of these pervasive metabolic vulnerabilities.

Identifiants

pubmed: 34585982
doi: 10.1128/MMBR.00123-21
pmc: PMC8483676
doi:

Substances chimiques

Phosphates 0
Xylose A1TA934AKO
Arabinose B40ROO395Z
Lactose J2B2A4N98G
Galactose X2RN3Q8DNE

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0012321

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI140541
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116119
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143288
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM068412
Pays : United States

Auteurs

Erin F Boulanger (EF)

Department of Microbial Infection and Immunity, The Ohio State Universitygrid.261331.4, Columbus, Ohio, USA.

Anice Sabag-Daigle (A)

Department of Microbial Infection and Immunity, The Ohio State Universitygrid.261331.4, Columbus, Ohio, USA.

Pankajavalli Thirugnanasambantham (P)

Department of Chemistry and Biochemistry, The Ohio State Universitygrid.261331.4, Columbus, Ohio, USA.
Center for RNA Biology, The Ohio State Universitygrid.261331.4, Columbus, Ohio, USA.

Venkat Gopalan (V)

Department of Chemistry and Biochemistry, The Ohio State Universitygrid.261331.4, Columbus, Ohio, USA.
Center for RNA Biology, The Ohio State Universitygrid.261331.4, Columbus, Ohio, USA.

Brian M M Ahmer (BMM)

Department of Microbial Infection and Immunity, The Ohio State Universitygrid.261331.4, Columbus, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH